Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
STP-938 by Step Pharma for Marginal Zone B-cell Lymphoma: Likelihood of Approval
STP-938 is under clinical development by Step Pharma and currently in Phase II for Marginal Zone B-cell Lymphoma. According to...